CD74支持瘤中调节性T细胞的积累和功能
Elisa Bonnin1,2, Maria Rodrigo Riestra1,2, Federico Marziali1,2
1INSERM U932 Immunity and Cancer, PSL University, Institut Curie Research Center, Paris, France.
Nature communications
|May 3, 2024
概括
调节性T细胞 (Tregs) 在瘤中过度表达CD74. CD74删除会损害Treg功能并促进瘤排斥,突出显示CD74是癌症免疫治疗的标.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞生物学 细胞生物学
背景情况:
- 调节性T细胞 (Tregs) 对免疫平衡至关重要,但它们的瘤特异性功能尚不清楚.
- Tregs表现出可塑性,使其分子和功能配置文件适应不同的微环境,包括瘤.
研究的目的:
- 研究CD74的作用,CD74是一种过度表达的分子瘤透Tregs,在瘤微环境中的Treg功能.
- 确定是否针对CD74可能是增强抗瘤免疫力的策略.
主要方法:
- 在人类瘤透Tregs中对CD74表达的分析.
- 在初级人类Tregs (CD74KO Tregs) 中CD74的遗传删除.
- 在临床前模型中对CD74KO Treg表型,功能和瘤透的体外和体内评估.
主要成果:
- 人类瘤透Tregs选择性地过度表达CD74.
- 在Tregs中CD74删除导致细胞骨和器官组织的缺陷,激活的减少,Foxp3表达的减少和瘤积累的损害.
- 在临床前模型中,CD74KOTreg与瘤排斥加速有关,但在非瘤条件下对Treg功能没有影响.
结论:
- CD74是瘤透Treg功能和可塑性的特定调节者.
- CD74代表了一个潜在的治疗点,可以调节Treg介导的免疫抑制并增强抗瘤免疫反应.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
T Cell Activation and Clonal Selection
714
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
714
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


